Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Information
- Disease name
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05877040 | Active, not recruiting | Phase 2 | A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy | June 1, 2019 | September 30, 2023 |
| NCT00004772 | Completed | Phase 3 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy | September 1992 | |
| NCT00004939 | Completed | Phase 3 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy | August 1996 | August 1996 |
| NCT00220740 | Completed | Phase 3 | Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | April 2004 | June 2006 |
| NCT00305266 | Completed | Study of CIDP Patients During IVIG Treatment | August 2005 | August 2007 | |
| NCT01017159 | Completed | Phase 2 | Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | April 2010 | November 2011 |
| NCT02027701 | Completed | Phase 3 | Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | July 30, 2014 | July 10, 2017 |
| NCT03008733 | Completed | N/A | Descriptive Analysis of Morphological Aspects of Nerve by Ultra-high Frequency Ultrasound (30-50MHZ) in Demyelinating Neuropathies: Inflammatory Demyelinating Polyneuropathy Chronic (IPDC), Neuropathy Multifocal Motor Block of Conducting (NMMBC) and Neuropathy With Antibody A MAG | June 26, 2018 | September 30, 2021 |
| NCT00004286 | Completed | Phase 3 | Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy | February 1996 | November 1999 |
| NCT04742374 | Completed | Early Phase 1 | Effects of Single Plasma Exchange and Double Filtration Plasmapheresis (DFPP) on Peripheral Lymphocyte Phenotypes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy | February 1, 2021 | February 3, 2022 |
| NCT06325943 | Completed | Phase 3 | Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy | April 1, 2019 | November 30, 2023 |
| NCT05327114 | Recruiting | Phase 2/Phase 3 | Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | September 23, 2022 | September 30, 2028 |
| NCT03275740 | Terminated | Phase 1 | A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 | July 17, 2017 | January 6, 2023 |
| NCT02271724 | Unknown status | sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN | September 2015 | November 2016 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020277